Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine
Status: Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 05 Nov 2019
Price : $35 *
At a glance
- Drugs Topiramate (Primary) ; Topiramate (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 19 Jul 2019 Status changed from discontinued to withdrawn prior to enrolment.
- 09 Oct 2018 Status changed from recruiting to discontinued.
- 15 Sep 2017 New trial record